NUSPINE CHIROPRACTIC (UNIT)

Item 7 lays out a wide initial investment spectrum of $175,450 to $550,250, kicked off by a $49,000 franchise fee—positioning it as mid-tier for medical services. Royalty hits 7%, plus 1% brand fund, but watch the $3,000 monthly local ad minimum and $549-$699 tech fee, which could squeeze cash flow in early years without Item 19 revenue disclosure to benchmark AUVs or profits. Absent earnings claims, SBA stats become crucial: 7 loans averaging $328,614 suggest banks see viability, especially for a model targeting everyday chiropractic seekers over high-end wellness.

System maturity shines with 32 units in 2023 ballooning to 34 in 2024—a solid 6% bump—and 3 projected openings signaling controlled ambition over reckless scaling. Only 2 terminations reflect low churn in a regulation-heavy niche, where the P.C. partnership ensures compliance but demands vetted local chiropractors. For investors eyeing healthcare without med school debt, NuSpine's affordable care angle and financing track record merit scrutiny against regional demand and competitor density to gauge true ROI potential.